Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This article helps you determine Which Aristocrats ETF Has The Lowest Fees by comparing expense ratios and related costs across top funds.
27,507 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
UPS stock in 2026 looks like a pendulum: moments of strength followed by pullbacks, driven by mixed earnings signals ...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
NVIDIA stock hasn't been this affordable in years, but cheap price tags don't guarantee gains. This guide breaks down...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...
XRP has fallen more than ripple's in the latest market cycle, even as Ripple signs big-bank deals and the XRP Ledger ...
Meta Platforms and Snap compete for digital ad dollars and user engagement. This guide breaks down their revenue engi...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...